BioScrip reports double-digit increases
ELMSFORD, N.Y. – BioScrip reports revenue from continuing operations was $239.6 million in the first quarter of 2014, an increase of 32.3% over the same period last year. In the Infusion Services segment, revenue grew to $221.4 million, an increase of 43.4%, driven primarily by BioScrip’s acquisitions of HomeChoice and CarePoint, along with organic growth. Consolidated gross profit was 27.2% higher for the first quarter of this year compared to the same period last year. Adding to BioScrip’s earnings picture: In March, the company sold Deaconess HomeCare for $60 million and used the proceeds to pay down a portion of outstanding debt.